How does adenomyosis impact endometrial receptivity? An updated systematic review of clinical and molecular insights
F&S Reviews, ISSN: 2666-5719, Vol: 4, Issue: 1, Page: 15-25
2023
- 9Citations
- 20Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Review Description
To summarize current knowledge regarding the outcomes of assisted reproductive technology (ART) in patients with adenomyosis, offer insights into the defects in the regulation of endometrial receptivity, and discuss the implications for the clinical management of adenomyosis and infertility. We conducted a comprehensive literature search of PubMed for original and review articles published in English up to June 2022 in the following areas: adenomyosis and infertility; ART; endometrial receptivity; and embryo implantation. Adenomyosis may have a negative impact on endometrial receptivity, reducing the probability of conception by ART. The severity of adenomyosis seems to be associated with the severity of the impairment in receptivity, and before treatment with a gonadotropin-releasing hormone agonist before frozen-thawed embryo transfer may restore endometrial receptivity. Molecular analyses demonstrated that genes associated with endometrial receptivity are aberrantly expressed in the eutopic endometria of women with infertility with adenomyosis. Hyperproliferation of the endometrial epithelium, impaired decidualization, progesterone resistance, altered expression of adhesion molecules, a hyperinflammatory microenvironment, chronic endometritis, and abnormal uterine contractility seem to be involved in the impairment of endometrial receptivity. Uterine adenomyosis reduces endometrial receptivity via several mechanisms. In addition, data suggest that the etiologic mechanism of adenomyosis is responsible for impaired endometrial receptivity. Before treatment with a gonadotropin-releasing hormone agonist before frozen-thawed embryo transfer may ameliorate the defects in the uterine environment, probably by restoring the expression of genes that are essential for embryo implantation. Further research using animal models should aim to additionally clarify the relationship between adenomyosis and infertility to refine the treatment strategies for women with infertility with adenomyosis.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2666571922000196; http://dx.doi.org/10.1016/j.xfnr.2022.11.004; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85146562100&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/S2666571922000196; https://dx.doi.org/10.1016/j.xfnr.2022.11.004
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know